Status: current, Defined. Date: 31-Mar 2016. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3039241000168114 | Actemra (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL syringes (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3039251000168111 | Actemra 162 mg/0.9 mL injection, 4 x 0.9 mL syringes | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Actemra (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL syringes (containered trade product pack) | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Actemra (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL syringes (containered trade product pack) | Is a | Actemra 162 mg/0.9 mL injection, 4 x 0.9 mL syringes | true | Inferred relationship | Some | ||
| Actemra (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL syringes (containered trade product pack) | has TPUU | Actemra 162 mg/0.9 mL injection, 0.9 mL syringe | true | Inferred relationship | Some | 1 | |
| Actemra (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL syringes (containered trade product pack) | has container type | syringe | true | Inferred relationship | Some | ||
| Actemra (tocilizumab 162 mg / 0.9 mL) injection, 4 x 0.9 mL syringes (containered trade product pack) | has TP | Actemra | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR